gamma-glutamylcysteine has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, X; Lu, S; Luo, L; Shi, Y; Yang, C; Yin, Z; Zhao, L; Zhou, D; Zhou, J | 1 |
| Mousavi, SH; Parsaee, H; Tayarani, NZ | 1 |
2 other study(ies) available for gamma-glutamylcysteine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
γ-glutamylcysteine alleviates insulin resistance and hepatic steatosis by regulating adenylate cyclase and IGF-1R/IRS1/PI3K/Akt signaling pathways.
Topics: Adenylyl Cyclases; Animals; Diabetes Mellitus, Type 2; Dipeptides; Fatty Liver; Insulin; Insulin Resistance; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction | 2023 |
Protective effect of saffron extract and crocin on reactive oxygen species-mediated high glucose-induced toxicity in PC12 cells.
Topics: Animals; Antioxidants; Carotenoids; Cell Survival; Crocus; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Dipeptides; Disease Models, Animal; Glucose; Humans; Neuroprotective Agents; Oxidative Stress; PC12 Cells; Plant Extracts; Rats; Reactive Oxygen Species | 2010 |